Cargando…

HPV transcription in skin tumors

BACKGROUND: Although more than 95% of viral sequences found in skin tumors typically belong to human papillomaviruses (HPVs), HPV transcription has so far not been detected. As current technology allows very deep transcriptome sequencing, we examined skin tumors and precursor lesions for HPV transcr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hultin, Emilie, Arroyo Mühr, Laila Sara, Lagheden, Camilla, Dillner, Joakim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544312/ https://www.ncbi.nlm.nih.gov/pubmed/31150522 http://dx.doi.org/10.1371/journal.pone.0217942

Ejemplares similares

Deep sequencing extends the diversity of human papillomaviruses in human skin
por: Bzhalava, Davit, et al.
Publicado: (2014)

De novo sequence assembly requires bioinformatic checking of chimeric sequences
por: Arroyo Mühr, Laila Sara, et al.
Publicado: (2020)

Improving human papillomavirus (HPV) testing in the cervical cancer elimination era: The 2021 HPV LabNet international proficiency study
por: Arroyo Mühr, Laila Sara, et al.
Publicado: (2022)

Human papillomavirus type 16 genomic variation in women with subsequent in situ or invasive cervical cancer: prospective population-based study
por: Arroyo-Mühr, Laila Sara, et al.
Publicado: (2018)

Deep sequencing detects human papillomavirus (HPV) in cervical cancers negative for HPV by PCR
por: Arroyo Mühr, Laila Sara, et al.
Publicado: (2020)

Viruses in case series of tumors: Consistent presence in different cancers in the same subject
por: Arroyo Mühr, Laila Sara, et al.
Publicado: (2017)

Comparison of DNA and RNA sequencing of total nucleic acids from human cervix for metagenomics
por: Arroyo Mühr, Laila Sara, et al.
Publicado: (2021)

Assessment of bacterial and viral gut communities in healthy and tumoral colorectal tissue using RNA and DNA deep sequencing
por: Garcia‐Serrano, Ainhoa, et al.
Publicado: (2023)

Head-to-Head Comparison of Bi- and Nonavalent Human Papillomavirus Vaccine-Induced Antibody Responses( )
por: Arroyo Mühr, Laila Sara, et al.
Publicado: (2022)

Detection of DNA viruses in prostate cancer
por: Smelov, Vitaly, et al.
Publicado: (2016)

Corrigendum: Detection of DNA viruses in prostate cancer
por: Smelov, Vitaly, et al.
Publicado: (2016)

Metatranscriptome analysis in human papillomavirus negative cervical cancers
por: Ure, Agustin Enrique, et al.
Publicado: (2022)

Antibodies to SARS-CoV-2 and risk of past or future sick leave
por: Dillner, Joakim, et al.
Publicado: (2021)

Nationwide comprehensive human papillomavirus (HPV) genotyping of invasive cervical cancer
por: Lagheden, Camilla, et al.
Publicado: (2018)

Using HPV-meta for human papillomavirus RNA quality detection
por: Ure, Agustin, et al.
Publicado: (2022)

Extension of the viral ecology in humans using viral profile hidden Markov models
por: Bzhalava, Zurab, et al.
Publicado: (2018)

Mapping HPV 16 Sub-Lineages in Anal Cancer and Implications for Disease Outcomes
por: Guerendiain, Daniel, et al.
Publicado: (2022)

Impact of cervical screening by human papillomavirus genotype: Population-based estimations
por: Wang, Jiangrong, et al.
Publicado: (2023)

Clinical validation of full genotyping CLART® HPV4S assay on SurePath and ThinPrep collected screening samples according to the international guidelines for human papillomavirus test requirements for cervical screening
por: Ejegod, Ditte Møller, et al.
Publicado: (2020)

Quality assurance in human papillomavirus testing for primary cervical screening
por: Cuschieri, Kate, et al.
Publicado: (2023)

Differences in risk for SARS-CoV-2 infection among healthcare workers
por: Elfström, K. Miriam, et al.
Publicado: (2021)

Immunogenicity of HPV prophylactic vaccines: Serology assays and their use in HPV vaccine evaluation and development
por: Pinto, Ligia A., et al.
Publicado: (2018)

High-risk human papillomavirus status and prognosis in invasive cervical cancer: A nationwide cohort study
por: Lei, Jiayao, et al.
Publicado: (2018)

Differing Age-Specific Cervical Cancer Incidence Between Different Types of Human Papillomavirus: Implications for Predicting the Impact of Elimination Programs
por: Vänskä, Simopekka, et al.
Publicado: (2020)

Cervical screening and risk of adenosquamous and rare histological types of invasive cervical carcinoma: population based nested case-control study
por: Andrae, Bengt, et al.
Publicado: (2019)

Genome-wide transcriptome profiling of ex-vivo precision-cut slices from human pancreatic ductal adenocarcinoma
por: Ghaderi, Mehran, et al.
Publicado: (2020)

Human Papillomavirus Detection by Whole-Genome Next-Generation Sequencing: Importance of Validation and Quality Assurance Procedures
por: Arroyo Mühr, Laila Sara, et al.
Publicado: (2021)

Long term duration of protective effect for HPV negative women: follow-up of primary HPV screening randomised controlled trial
por: Elfström, K Miriam, et al.
Publicado: (2014)

Human papillomavirus vaccine efficacy against invasive, HPV-positive cancers: population-based follow-up of a cluster-randomised trial
por: Lehtinen, Matti, et al.
Publicado: (2021)

Minor Cytological Abnormalities and up to 7-Year Risk for Subsequent High-Grade Lesions by HPV Type
por: Persson, Maria, et al.
Publicado: (2015)

Human papillomavirus genotype-specific risks for cervical intraepithelial lesions
por: Nygård, Mari, et al.
Publicado: (2020)

Role of human papillomavirus (HPV) vaccination on HPV infection and recurrence of HPV related disease after local surgical treatment: systematic review and meta-analysis
por: Kechagias, Konstantinos S, et al.
Publicado: (2022)

Different Challenges in Eliminating HPV16 Compared to Other Types: A Modeling Study
por: Baussano, Iacopo, et al.
Publicado: (2017)

Impact of HPV vaccination on cervical screening performance: a population-based cohort study
por: Lei, Jiayao, et al.
Publicado: (2020)

European guidelines for quality assurance in cervical cancer screening. Summary of the supplements on HPV screening and vaccination
por: von Karsa, Lawrence, et al.
Publicado: (2015)

Prevention and Treatment of HPV-Induced Skin Tumors
por: Hasche, Daniel, et al.
Publicado: (2023)

Recurrent Respiratory Papillomatosis: HPV Genotypes and Risk of High-Grade Laryngeal Neoplasia
por: Omland, Turid, et al.
Publicado: (2014)

Distribution of HPV Genotypes Differs Depending on Behavioural Factors among Young Women
por: Bergqvist, Laura, et al.
Publicado: (2021)

The Participation of HPV-Vaccinated Women in a National Cervical Screening Program: Population-Based Cohort Study
por: Herweijer, Eva, et al.
Publicado: (2015)

Competitive enzymatic reaction to control allele-specific extensions
por: Hultin, Emilie, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_sfdfcrm3sj780dgkkqn52kp0m3